• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Health News > October 22, 2010

      Probe Pressure Over Knee Implant

      Posted AtTheintelligencer.net

      Fortunately, it appears the hundreds of patients in the United States and Europe who have had Menaflex hip implant surgery since 2008 will suffer no long-term ill effects. But it appears they will not benefit from the implants, either, according to the Food and Drug Administration.

      FDA officials admitted last week they approved sale of the Menaflex implants, intended to reinforce damaged knee tissue, despite protests from scientists in the agency.

      The decision to go ahead - again, over the protests of FDA scientists - was made as a result of outside pressure, the agency admits. Some of the lobbying was by four members of Congress from New Jersey, where ReGen Biologics, the Menaflex manufacturer, is located.

      Menaflex is being taken off the market, the FDA announced. The devices are intended to be absorbed by the body, so patients should not be harmed.

      But, again, they received no benefit from the implants, either, according to the FDA.

      Congress should investigate the fiasco - with special attention to lawmakers who improperly pressured the FDA. Americans are entitled to be able to rely on the agency for scientific evaluation of food, drugs and medical devices.

      Oct 22, 2010


       

      Share this Article!

    Back to top^